Back
MediciNova 10K Form
Buy
70
MNOV
MediciNova
Last Price:
2.13
Seasonality Move:
0.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | MNOV/MediciNova Quarterly |
| 2023-11-09 | 10Q | MNOV/MediciNova Quarterly |
| 2023-08-09 | 10Q | MNOV/MediciNova Quarterly |
| 2023-05-11 | 10Q | MNOV/MediciNova Quarterly |
| 2022-11-10 | 10Q | MNOV/MediciNova Quarterly |
| 2022-08-11 | 10Q | MNOV/MediciNova Quarterly |
Receive MNOV News And Ratings
See the #1 stock for the next 7 days that we like better than MNOV
MNOV Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-2.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.17 |
| Price / Book: | 1.82 |
Profitability
| EPS (TTM): | -0.16000 |
|---|---|
| Net Income (TTM): | $-8.16M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
MediciNova Earnings Forecast
Key MediciNova Financial Ratios
- The Selling, General & Administrative Expenses for MNOV have been equal to 524.24% of Gross Profit Margin.
- The Research & Development expenses have been 565.79% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 23 years have been positive in 13 years.
MediciNova Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNOV |
| CUSIP: | 58468P |
| Website: | medicinova.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MNOV Technical Analysis vs Fundamental Analysis
Buy
70
MediciNova (MNOV)
is a Buy
Is MediciNova a Buy or a Sell?
-
MediciNova stock is rated a Buy
The current MediciNova [MNOV] share price is $2.13. The Score for MNOV is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.